Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment in Patients With Extended Criteria

NCT ID: NCT02871531

Last Updated: 2019-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

178 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-11-30

Study Completion Date

2023-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: To compare outcomes of retinal detachment repair following pneumatic retinopexy (PnR) versus pars plana vitrectomy in terms of anatomical success, functional success and patient quality of life in patients with extended criteria.

Methods: A prospective, randomized, controlled trial will be conducted with 178 patients presenting at St. Michael's Hospital with primary retinal detachment (RD). Inclusion criteria include: a single or multiple retinal tears in detached retina between 7 and 5 o'clock being of any size and any distance apart from each other, including giant retinal tears with inferior aspect above 5 and 7 o'clock, RD with no identifiable tear but where suspected tear is between 7 and 5 o'clock, retinoschisis with RD if tears are located between 7 and 5 o'clock, mild proliferative vitreoretinopathy, none or mild vitreous hemorrhage. Patients will be excluded if there is a small retinal tear or multiple tears less than 30o apart between 8 and 4 o'clock in detached retina, retinal tear in detached retina between 5 and 7 o'clock, \<18 years old, inability to read English, mental incapacity, previous history of RD, scleral buckle or vitrectomy in index eye, inability to maintain appropriate head posture at post-operative period and inability to visualize peripheral retinal due to media opacity. Patients will be randomly allocated into two groups: PnR + cryotherapy/laser or vitrectomy + cryotherapy/laser and the intervention will take place within 24 hours and 72 hours for attached and detached macula status, respectively. Patients will undergo a complete ophthalmological examination, including visual acuity and fundus assessment at baseline and at 3, 6 and 12 months after surgery. Visual acuity will also be measured at 1, 7 and 30 days after surgery. Global health related quality of life will be evaluated with the SF-36v2 questionnaire at baseline, 1 month, 1 and 2 years after intervention, while the VFG25 questionnaire will be applied at 3, 6, 12 and 24 months after surgery to measure vision related quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rhegmatogenous Retinal Detachment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pneumatic retinopexy

Patients with retinal detachment allocated to pneumatic retinopexy

Group Type EXPERIMENTAL

Pneumatic retinopexy

Intervention Type PROCEDURE

Vitrectomy

Patients with retinal detachment allocated to vitrectomy

Group Type EXPERIMENTAL

Vitrectomy

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pneumatic retinopexy

Intervention Type PROCEDURE

Vitrectomy

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Pneumatic retinopexy plus laser/cryotherapy Pars plana vitrectomy plus laser/cryotherapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Single retinal tear or group of tears (any distance apart) in detached retina located between 7 and 5 o'clock.
* Retinal detachment with no identifiable tear but where suspected tear is located between 7-5 o'clock based on Lincoff rules
* Any size of retinal tear, including giant retinal tears, if the inferior aspect of it is above 5 and 7 o'clock
* Retinoschisis with retinal detachment if tears are located between 7 and 5 o'clock
* There may be mild proliferative vitreoretinopathy (unless there is a visible traction on the break)
* None or mild vitreous hemorrhage. Note: vitreous hemorrhage will be considered mild if it does not impair an adequate examination of the retinal periphery.
* In the opinion of the investigator, PnR is likely to achieve anatomical re-attachment of the retina

Exclusion Criteria

* Group of tears \<30o apart in detached retina if all located within 8-4 o'clock
* Single retinal tear smaller than 1 o'clock in detached retina between 8-4 o'clock
* Retinal tears below the 5 and 7 o'clock meridian in detached retina (note that additional tears in attached retina are acceptable)
* Inability to read English language
* Age \<18 years
* Mental incapacity
* Previous vitrectomy or scleral buckle (index eye)
* Previous retinal detachment (index eye)
* Inability to maintain the strict post-operative posturing requirements of pneumatic retinopexy
* Inability to carry out detailed examination of the peripheral retina due to media opacity NOTE: Lens/posterior hyaloid status does not affect eligibility.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Unity Health Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rajeev Muni, FRSCS

Role: PRINCIPAL_INVESTIGATOR

staff

Verena Juncal, MD

Role: PRINCIPAL_INVESTIGATOR

research fellow

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Michael's Hospital Eye Clinic

Toronto, Ontario, Canada

Site Status RECRUITING

Sunnybrook Health Sciences Centre

Toronto, , Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rajeev Muni, MD

Role: CONTACT

416-867-7411

Veren Juncal, MD

Role: CONTACT

416-867-7411

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rajeev Muni, MD Msc FRCSC

Role: primary

4168677411

Phillip To

Role: backup

4168677411

Peter Kertes

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Extended criteria pneumaticPPV

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

REtinal Detachment Outcomes Study
NCT05863312 RECRUITING NA
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
NCT02858076 COMPLETED PHASE2/PHASE3